Africa's health crisis persists as governments finance too little, while patients pay too much for free medicines crucial for universal health coverage.
The drug is marketed globally by Novo Nordisk as Ozempic for Type 2 diabetes and for obesity, and has been at the centre of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback